Physician profile
Arthur Jay Brantz
NPI 1154379287
$1,197.60
in general payments reported to CMS, 2019-2025
20 companies · $425 in 2025
The $425 reported for 2025 was more than what 81% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $20.76 · 2021: $64.15 · 2022: $48.71 · 2023: $113 · 2024: $345 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $315.78 | 2024-2025 | Rexulti |
| Gilead Sciences, INC. | $161.63 | 2019 | |
| Abbvie INC. | $105.82 | 2023-2025 | Mavyret |
| Astellas Pharma US INC | $87.65 | 2025 | Veozah |
| Lilly USA, LLC | $70.78 | 2022-2024 | Mounjaro |
| Amarin Pharma, INC. | $60.92 | 2020-2021 | |
| Lundbeck LLC | $56.14 | 2025 | Rexulti |
| Pfizer INC. | $48.87 | 2024 | |
| Exact Sciences Corporation | $48.05 | 2023 | Cologuard Collection Kit |
| Abiomed | $31.50 | 2025 | |
| Insmed, INC. | $25.00 | 2025 | Arikayce |
| Esperion Therapeutics, INC. | $23.99 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.71 | 2022 | |
| Hologic Sales and Service, LLC | $23.46 | 2025 | Aptima |
| Smith+Nephew, INC. | $20.49 | 2023 | Regranex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $20.44 | 2025 | Recorlev |
| Shield Therapeutics INC | $20.20 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $19.97 | 2024 | Kristalose |
| Novo Nordisk INC | $19.05 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.15 | 2024 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Brantz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.